Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLI and ATG Non-myeloablative Transplant for CTCL
NCT00896493Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2009
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF), Sézary syndrome (SS), sponsored by Stanford University. Started May 2009; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
cutaneous T-cell lymphoma (CTCL)mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT00896493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896493.